Ausgabe 2/2013
Inhalt (31 Artikel)
Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response
Jessica Anna Cintolo, Julia Tchou, Daniel A. Pryma
A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer
Iben Kümler, Nils Brünner, Jan Stenvang, Eva Balslev, Dorte L. Nielsen
Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
Nigel J. Bundred, Ramachandran Prasad, Julie Morris, W. Fiona Knox, Ged Byrne, Shan Cheung, Mary Wilson, Gill Lawrence
PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
Seth A. Wander, Dekuang Zhao, Alexandra H. Besser, Feng Hong, Jianqin Wei, Tan A. Ince, Clara Milikowski, Nanette H. Bishopric, Andy J. Minn, Chad J. Creighton, Joyce M. Slingerland
TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells
Yu-Peng Liu, Hui-Ling Chen, Cherng-Chyi Tzeng, Pei-Jung Lu, Cheng-Wei Lo, Yu-Cheng Lee, Chih-Hua Tseng, Yeh-Long Chen, Chia-Ning Yang
The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding
Olga P. Rogozina, Katai J. Nkhata, Emily J. Nagle, Joseph P. Grande, Margot P. Cleary
Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer
Amir Sonnenblick, Beatrice Uziely, Hovav Nechushtan, Luna Kadouri, Eithan Galun, Jonathan H. Axelrod, Daniela Katz, Hagit Daum, Tamar Hamburger, Bela Maly, Tanir M. Allweis, Tamar Peretz
αB-Crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation
Vladimir Petrovic, Dmitry Malin, Vincent L. Cryns
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
Alvaro Moreno-Aspitia, Amylou C. Dueck, Ismael Ghanem-Cañete, Tejal Patel, Shaker Dakhil, David Johnson, Sandra Franco, Stephen Kahanic, Gerardo Colon-Otero, Kathleen S. Tenner, Richard Rodeheffer, Ann E. McCullough, Robert B. Jenkins, Frances M. Palmieri, Donald Northfelt, Edith A. Perez
Isogenic human mammary epithelial cell lines: novel tools for target identification and validation
Ulrike Ulbricht, Anette Sommer, Georg Beckmann, Manuel Lutzenberger, Henrik Seidel, Bertolt Kreft, Luisella Toschi
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
Miguel Martín, Aleix Prat, Álvaro Rodríguez-Lescure, Rosalía Caballero, Mark T. W. Ebbert, Blanca Munárriz, Manuel Ruiz-Borrego, Roy R. L. Bastien, Carmen Crespo, Carole Davis, César A. Rodríguez, José M. López-Vega, Vicente Furió, Ana M. García, Maribel Casas, Matthew J. Ellis, Donald A. Berry, Brandelyn N. Pitcher, Lyndsay Harris, Amparo Ruiz, Eric Winer, Clifford Hudis, Inge J. Stijleman, David P. Tuck, Eva Carrasco, Charles M. Perou, Philip S. Bernard
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
Johan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per-Olof Malmström, Arne Wallgren, Olle Stål, John Carstensen
Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort
Ye Won Jeon, Jung Eun Choi, Heung Kyu Park, Ku Sang Kim, Jee Yeon Lee, Young Jin Suh
Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome
M. Synnestvedt, E. Borgen, E. Schlichting, C. B. Schirmer, A. Renolen, K. E. Giercksky, J. M. Nesland, B. Naume
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
Olöf Bjarnadottir, Quinci Romero, Pär-Ola Bendahl, Karin Jirström, Lisa Rydén, Niklas Loman, Mathias Uhlén, Henrik Johannesson, Carsten Rose, Dorthe Grabau, Signe Borgquist
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse
A. D. Hartkopf, M. Banys, F. Meier-Stiegen, M. Hahn, C. Röhm, J. Hoffmann, G. Helms, F. A. Taran, M. Wallwiener, C. Walter, H. Neubauer, D. Wallwiener, T. Fehm
Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis
Nataliya G. Batina, Amy Trentham-Dietz, Ronald E. Gangnon, Brian L. Sprague, Marjorie A. Rosenberg, Natasha K. Stout, Dennis G. Fryback, Oguzhan Alagoz
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Rebecca Hein, Dieter Flesch-Janys, Norbert Dahmen, Lars Beckmann, Sara Lindström, Nils Schoof, Kamila Czene, Kirstin Mittelstraß, Thomas Illig, Petra Seibold, Sabine Behrens, Keith Humphreys, Jingmei Li, Jianjun Liu, Janet E. Olson, Xianshu Wang, Susan E. Hankinson, Thérèse Truong, Florence Menegaux, Isabel dos Santos Silva, Nichola Johnson, Shou-Tung Chen, Jyh-Cherng Yu, Argyrios Ziogas, Vesa Kataja, Veli-Matti Kosma, Arto Mannermaa, Hoda Anton-Culver, Chen-Yang Shen, Hiltrud Brauch, Julian Peto, Pascal Guénel, Peter Kraft, Fergus J. Couch, Douglas F. Easton, Per Hall, Jenny Chang-Claude
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant
Ofure Obazee, Christina Justenhoven, Stefan Winter, Jenny Chang-Claude, Anja Rudolph, Petra Seibold, Dieter Flesch-Janys, Ulf Hannelius, Jingmei Li, Keith Humphreys, Per Hall, Graham Giles, Gianluca Severi, Laura Baglietto, Melissa Southey, Sylvia Rabstein, Volker Harth, Anne Lotz, Beate Pesch, Thomas Brüning, Christian Baisch, Yon-Dschun Ko, Ute Hamann, Hiltrud Brauch
Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer
Eryn B. Callihan, Dexiang Gao, Sonali Jindal, Traci R. Lyons, Elizabeth Manthey, Susan Edgerton, Alexander Urquhart, Pepper Schedin, Virginia F. Borges
Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis
N. A. de Glas, M. Kiderlen, E. Bastiaannet, A. J. M. de Craen, W. van de Water, C. J. H. van de Velde, G. J. Liefers
Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women
Adana A. Llanos, Theodore M. Brasky, Ramona G. Dumitrescu, Catalin Marian, Kepher H. Makambi, Bhaskar V. S. Kallakury, Scott L. Spear, David J. Perry, Rafael J. Convit, Mary E. Platek, Lucile L. Adams-Campbell, Jo L. Freudenheim, Peter G. Shields
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis
Eileen Rakovitch, Sharon Nofech-Mozes, Steven A. Narod, Wedad Hanna, Deva Thiruchelvam, Refik Saskin, Carole Taylor, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A. Jani, Susan J. Done, Naomi Miller, Bruce Youngson, Iwa Kong, Lawrence Paszat
The prognostic impact of age in patients with triple-negative breast cancer
Cornelia Liedtke, K. R. Hess, T. Karn, A. Rody, L. Kiesel, G. N. Hortobagyi, L. Pusztai, A. M. Gonzalez-Angulo
Body size throughout the life course and mammographic density in Mexican women
Megan S. Rice, Kimberly A. Bertrand, Martin Lajous, Rulla M. Tamimi, Gabriela Torres-Mejía, Carine Biessy, Ruy López-Ridaura, Isabelle Romieu
Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women
Bassam Lajin, Amir Alhaj Sakur, Amal Alachkar
Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy
Victoria M. Chia, John H. Page, Roberto Rodriguez, Su-Jau Yang, Julie Huynh, Chun Chao
A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase
Ningqi Hou, Dezheng Huo
Too many statistical errors for meaningful interpretation
A. Stang, E. Kantelhardt
Earwax type and osmidrosis: prognostic factor for breast cancer?
Yang Sun, Jianhong Long
Need for clarification of data in a recent meta-analysis about polymorphisms in the leptin receptor gene and risk of breast cancer
Qiliu Peng, Xianjun Lao, Shan Li, Xue Qin